Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,062 across all filing types
Latest filing 2014-06-13 Director's Dealing
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2014-06-13 English
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 10, 2014, reporting an event related to the company entering into an Underwriting Agreement for the sale of $1.75 billion in Senior Notes. The content focuses on a financing transaction, specifically the issuance of debt securities, and includes details about the underwriting agreement and the expected closing date. There are no financial statements or comprehensive financial performance data presented, so it is not an Annual Report, Interim Report, or Earnings Release. The document is not a proxy, voting result, or management change announcement. The primary subject is a capital raising activity through debt issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 3420 characters, which is sufficient to contain substantive information about the financing event rather than just an announcement of a report publication or a certification. Confidence is high due to clear references to underwriting and debt issuance.
2014-06-12 English
424B5 Filing
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus supplement and accompanying prospectus related to a $1.75 billion offering of 5.125% Senior Notes due 2024 by DaVita HealthCare Partners Inc. It includes registration fee calculations, terms of the notes, risk factors, underwriting details, and legal disclaimers. The document is a formal offering document filed pursuant to the Securities Act of 1933, specifically a prospectus supplement under Rule 424(b)(5). This type of document is a capital markets financing disclosure, providing detailed information about a debt issuance. It is not an annual or quarterly report, audit report, earnings release, or any other type of report. It is a financing update related to the issuance of senior notes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is the actual offering document, not just an announcement or a brief summary.
2014-06-12 English
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 10, 2014, for DaVita HealthCare Partners Inc. The key content is the announcement of the pricing of $1.75 billion senior notes, which is a financing activity. The document includes a press release as an exhibit. The length is 2709 characters, which is relatively short and primarily an announcement rather than a detailed report. The nature of the content relates to capital raising through senior notes issuance, which fits the Capital/Financing Update category. Therefore, the appropriate classification is CAP (Capital/Financing Update).
2014-06-11 English
8-K Filing
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 10, 2014, for DaVita HealthCare Partners Inc. The key content is a press release announcing an offering of $1.75 billion senior notes. This indicates a financing activity. The document is short (2710 characters) and primarily serves as an announcement of a capital raising event. There are no financial statements or detailed financial analysis included, just a press release attached. Therefore, this fits the category of Capital/Financing Update (CAP).
2014-06-11 English
424B5 Filing
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933, related to a $1,750,000,000 offering of 5.125% Senior Notes due 2024 by DaVita HealthCare Partners Inc. It contains detailed information about the terms of the debt offering, interest payments, redemption rights, underwriting details, risk factors, use of proceeds, and legal matters. This type of document is a capital raising disclosure describing a debt issuance and financing terms. It is not an annual or quarterly report, audit report, earnings release, or any other type of report. It is a financing update related to the company's capital structure and debt issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed offering terms, supporting a high confidence in classification.
2014-06-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.